Puede desempear un papel en el metabolismo energtico del corazn, pero los beneficios reales para las personas sanas no estn claramente establecidos
Tkachev A, Stekolshchikova E, Vanyushkina A, Zhang H, Morozova A, Zozulya S, Kurochkin I, Anikanov N, Egorova A, Yushina E, et al
Table II EMPA-REG OUTCOME trial: BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients
The initiative aims to provide a holistic approach to weight management, combining pharmacotherapy with behavioral support
Gojaznost izaziva insulinsku rezistenciju, odnosno kod gojaznih osoba osetljivost na insulin opada
Neuroscience research: BPC-157 has been investigated for potential effects on neuronal cells in laboratory studies